SCM
DARA

Summit Capital Management’s DARA BIOSCIENCES INC COM STK (DE) DARA Stock Holding History

Summit Capital Management’s Portfolio DARA Stock Details DARA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-2,000
Closed -$5K – 77
2013
Q3 		$5K Hold
2,000
– – ﹤0.01% 48
2013
Q2 		$6K Buy
+2,000
New +$7.41K ﹤0.01% 45

Other funds holding DARA

BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BCA
Benchmark Capital Advisors New York $101M AUM 0.8% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
SKK
Shepherd Kaplan Krochuk Boston, Massachusetts $126M AUM 15.32% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

Summit Capital Management's DARA Position: Q4 2013 in Review

Summit Capital Management sold out of DARA BIOSCIENCES INC COM STK (DE) (DARA) in Q4 2013, closing a stake of 2,000 shares — an estimated $5K sold.

Summit Capital Management first reported a position in DARA in Q2 2013 and held it in 2 quarters. The position peaked at $6K in Q2 2013. 21 funds tracked by Wall St. Rank hold DARA as of Q4 2013.

  • Summit Capital Management reported no remaining DARA BIOSCIENCES INC COM STK (DE) position as of Q4 2013 after selling out during the quarter.
  • Summit Capital Management sold 2,000 DARA BIOSCIENCES INC COM STK (DE) shares in Q4 2013, an estimated $5K.
  • Summit Capital Management first reported a position in DARA BIOSCIENCES INC COM STK (DE) in Q2 2013 and held it in 2 quarters.
  • Summit Capital Management's DARA BIOSCIENCES INC COM STK (DE) position peaked at $6K in Q2 2013.
  • 21 funds tracked by Wall St. Rank held DARA BIOSCIENCES INC COM STK (DE) as of Q4 2013.

Based on Summit Capital Management's 13F filing for Q4 2013, filed 14 Feb 2014.